CLARINS Broad Spectrum SPF 15 Everlasting Foundation Tint 113 description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

CLARINS Broad Spectrum SPF 15 Everlasting Foundation Tint 113

Laboratoires Clarins S.A.

CLARINS Broad Spectrum SPF 15 Everlasting Foundation Tint 113


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Drug Facts


Active ingredient

TITANIUM DIOXIDE 2%

Purpose

Sunscreen

Uses:

• helps prevent sunburn
• if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

Warnings:

For external use only.

Do not use

• on damaged or broken skin

When using this product

• keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if

• rash occurs.

Keep out of reach of children.

If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions:

• apply liberally 15 minutes before sun exposure
• apply to all skin exposed to the sun
• children under 6 months: Ask a doctor
Sun Protection Measures.
Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including:
• limit time in the sun, especially from 10 a.m. – 2 p.m.
• wear long-sleeved shirts, pants, hats and sunglasses.
• reapply at least every 2 hours
• use a water resistant sunscreen if swimming or sweating.

Inactive ingredients

AQUA/WATER/EAU - CYCLOMETHICONE - CYCLOPENTASILOXANE - HDI/TRIMETHYLOL HEXYLLACTONE CROSSPOLYMER -  SODODECANE - BUTYLENE GLYCOL - ALCOHOL - NYLON-12 - PEG/PPG-20/15 DIMETHICONE - MAGNESIUM SULFATE - PEG-10 DIMETHICONE - POLYGLYCERYL-3 POLYDIMETHYLSILOXYETHYL DIMETHICONE - METHYL TRIMETHICONE - PARFUM/FRAGRANCE - POLYGLYCERYL- 3 DIISOSTEARATE - DISODIUM STEAROYL GLUTAMATE - ALUMINUM HYDROXIDE - ACRYLATES/DIMETHICONE COPOLYMER - STEARIC ACID - DIDISTEARDIMONIUM HECTORITE - ETHYLHEXYLGLYCERIN - SILICA - DISODIUM EDTA - HYDROXYETHYL UREA - SORBIC ACID - CAMELLIA SINENSIS LEAF EXTRACT - PHENOXYETHANOL - ALGIN - ACACIA SENEGAL GUM.

± / MAY CONTAIN/PEUT CONTENIR: [CI 77891/TITANIUM DIOXIDE . CI 77491/CI 77492/CI 77499/IRON OXIDES]. [M1922A]

Other information:

• protect this product from excessive heat and direct sun.

Questions or comments?

Call 1-866-252-7467 Monday-Friday, 8 a.m. to 5 p.m.

CLARINS

Simply everlasting: 15 hours of impeccable coverage and total comfort thanks to a non-oily, melting, smoothing texture which evens tone and enhances the complexion. For a flawless complexion under any circumstances. Matte finish. Full coverage. All skin types. Oil-free. Non-comedogenic. Dermatologist tested.  www.clarins.com  CLARINS PARIS 92200 Neuilly 95300 Pontoise - France Made in France

CLARINS PARIS  113 Teint Haute Tenue Broad Spectrum SPF 15 Titanium Dioxide - Sunscreen Everlasting Foundation e 30 mL 1.2 Oz. Net Wt.

Product Labels

CLARINS Broad Spectrum SPF 15 Everlasting Foundation Tint 113 CLARINS Broad Spectrum SPF 15 Everlasting Foundation Tint 113

CLARINS Broad Spectrum SPF 15 Everlasting Foundation Tint 113

TITANIUM DIOXIDE LIQUID

Product Information

Product Type Human otc drug label Item Code (Source) NDC:58668-2231
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
titanium dioxide 20 mg

Inactive Ingredients

Ingredient Name Strength
water
cyclomethicone
CYCLOMETHICONE 5
ISODODECANE
BUTYLENE GLYCOL
ALCOHOL
NYLON-12
PEG/PPG-20/15 DIMETHICONE
MAGNESIUM SULFATE
METHYL TRIMETHICONE
POLYGLYCERYL-3 DIISOSTEARATE
DISODIUM STEAROYL GLUTAMATE
aluminum hydroxide
STEARIC ACID
ETHYLHEXYLGLYCERIN
SILICON DIOXIDE
EDETATE DISODIUM
HYDROXYETHYL UREA
sorbic acid
GREEN TEA LEAF
PHENOXYETHANOL
ACACIA
ferric oxide red
FERRIC OXIDE YELLOW
FERROSOFERRIC OXIDE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 30 in 1 BOTTLE, PUMP
2 NDC:58668-2231-1 1 in 1 PACKAGE

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-02-08


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.